Concepedia

Oluwadara Coker

OC

7

Publications

290

Citations

7

H-Index

2020

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

The University of Texas Health Science Center at Houston

Oluwadara Coker is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

Top concepts

MedicineOncologyCancer ResearchMolecular OncologyRadiation OncologyPathologyPharmacologyTumor BiologyCancer BiologyCancer Therapy

Publications per year

2020–2024

7

Publications

7

KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy

Meagan B. Ryan, Oluwadara Coker, Alexey V. Sorokin et al. · Cell Reports · 2022 · 138 citations · Full text

Signal Transduction, Functional Selectivity, Medicine +7

Comprehensive Clinical and Molecular Characterization of <i>KRAS</i><sup>G12C</sup>-Mutant Colorectal Cancer

Jason T. Henry, Oluwadara Coker, Saikat Chowdhury et al. · JCO Precision Oncology · 2021 · 60 citations · Full text

Clinical and Functional Characterization of Atypical <i>KRAS</i> / <i>NRAS</i> Mutations in Metastatic Colorectal Cancer

Jonathan M. Loree, Yucai Wang, Muddassir Syed et al. · Clinical Cancer Research · 2021 · 36 citations · Full text

NeoRAS: Incidence of RAS reversion from RAS mutated to RAS wild type.

Jason T. Henry, Jason Willis, Christine M. Parseghian et al. · Journal of Clinical Oncology · 2020 · 20 citations

Reverse Genetics, Genetics, Ras Mut +22

A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance

Christopher E. Whitehead, Elizabeth K. Ziemke, Christy L. Frankowski-McGregor et al. · Nature Cancer · 2024 · 16 citations · Full text

Drug Target, Key Resistance Drivers, Adaptive Resistance +21

Rows per page

1–5 of 7